Engineered toxins "zymoxins" are activated by the HCV NS3 protease by removal of an inhibitory protein domain.
The synthesis of inactive enzyme precursors, also known as "zymogens," serves as a mechanism for regulating the execution of selected catalytic activities in a desirable time and/or site. Zymogens are usually activated by proteolytic cleavage. Many viruses encode proteases that execute key proteolytic steps of the viral life cycle. Here, we describe a proof of concept for a therapeutic approach to fighting viral infections through eradication of virally infected cells exclusively, thus limiting virus production and spread. Using the hepatitis C virus (HCV) as a model, we designed two HCV NS3 protease-activated "zymogenized" chimeric toxins (which we denote "zymoxins"). In these recombinant constructs, the bacterial and plant toxins diphtheria toxin A (DTA) and Ricin A chain (RTA), respectively, were fused to rationally designed inhibitor peptides/domains via an HCV NS3 protease-cleavable linker. The above toxins were then fused to the binding and translocation domains of Pseudomonas exotoxin A in order to enable translocation into the mammalian cells cytoplasm. We show that these toxins exhibit NS3 cleavage dependent increase in enzymatic activity upon NS3 protease cleavage in vitro. Moreover, a higher level of cytotoxicity was observed when zymoxins were applied to NS3 expressing cells or to HCV infected cells, demonstrating a potential therapeutic window. The increase in toxin activity correlated with NS3 protease activity in the treated cells, thus the therapeutic window was larger in cells expressing recombinant NS3 than in HCV infected cells. This suggests that the "zymoxin" approach may be most appropriate for application to life-threatening acute infections where much higher levels of the activating protease would be expected.
Department of Molecular Microbiology and Biotechnology, The George S. Wise Faculty of Life Sciences, Tel-Aviv University, Ramat Aviv, Israel.
Assaf
A
Shapira
Meital
M
Gal-Tanamy
Limor
L
Nahary
Dana
D
Litvak-Greenfeld
Romy
R
Zemel
Ran
R
Tur-Kaspa
Itai
I
Benhar
D000595:Amino Acid Sequence; D002460:Cell Line; D004167:Diphtheria Toxin; D004792:Enzyme Precursors; D004926:Escherichia coli / Q000235:genetics; D016174:Hepacivirus / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D010446:Peptide Fragments; D015202:Protein Engineering / Q000379:methods*; D017434:Protein Structure, Tertiary; D012276:Ricin; D017384:Sequence Deletion / Q000502:physiology*; D057057:Serine Proteases; D014118:Toxins, Biological / Q000138:chemical synthesis / Q000235:genetics*; D017361:Viral Nonstructural Proteins / Q000235:genetics / Q000378:metabolism*; D012697:Serine Endopeptidases; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases
D004167:Diphtheria Toxin; D004792:Enzyme Precursors; D010446:Peptide Fragments; D012276:Ricin; D057057:Serine Proteases; D014118:Toxins, Biological; D017361:Viral Nonstructural Proteins; C084422:NS3 protein, hepatitis C virus; D012697:Serine Endopeptidases; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases; C029795:diphtheria toxin fragment A
Semin Cell Biol. 1991 Feb;2(1):31-7
1954341
J Virol. 2004 Aug;78(15):7904-15
15254163
Cell. 1987 Jan 16;48(1):129-36
3098436
Infect Immun. 1977 Jan;15(1):138-44
188760
Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14545-50
18799730
Antiviral Res. 2003 Oct;60(2):103-9
14638405
Biochem J. 1999 Oct 1;343 Pt 1:199-207
10493930
J Biol Chem. 1995 May 26;270(21):12933-40
7759553
Biochem J. 2006 Oct 15;399(2):225-9
16817779
Exp Cell Res. 2007 Sep 10;313(15):3189-97
17643420
Biochem J. 1995 Apr 1;307 ( Pt 1):29-37
7717988
Cell Mol Life Sci. 2006 Aug;63(16):1850-66
16799768
J Virol. 1996 Oct;70(10):6694-700
8794305
Proc Natl Acad Sci U S A. 1975 Jun;72(6):2284-8
166383
Gene Ther. 2003 Apr;10(8):686-99
12692597
Antiviral Res. 2008 Dec;80(3):251-65
18789977
J Virol. 2007 Jan;81(2):629-38
17079282
Toxicon. 2004 Sep 15;44(4):361-70
15302520
Protein Sci. 1998 Oct;7(10):2143-9
9792101
Mol Microbiol. 1992 May;6(10):1281-7
1640830
FEBS J. 2006 Dec;273(23):5457-65
17116245
EMBO J. 1989 Jan;8(1):301-8
2714255
Nat Struct Biol. 2003 Feb;10(2):115-9
12496934
J Hepatol. 2004 Jun;40(6):1000-7
15158342
Infect Immun. 1996 Feb;64(2):524-7
8550202
J Biol Chem. 2003 Dec 19;278(51):50819-32
14570883
J Biol Chem. 1995 Dec 22;270(51):30581-7
8530493
Nucleic Acids Res. 2009 Feb;37(2):602-10
19073700
J Mol Biol. 2008 Apr 25;378(2):375-86
18358491
J Immunol Methods. 2005 Aug;303(1-2):19-39
16045924
J Virol Methods. 2003 Feb;107(2):245-55
12505640
Adv Drug Deliv Rev. 2007 Oct 10;59(12):1200-12
17825945
Science. 1999 Jul 2;285(5424):110-3
10390360
Protein Eng. 1998 Dec;11(12):1257-65
9930676
Acta Biochim Pol. 2007;54(4):703-15
17957276
Mol Microbiol. 2008 Dec;70(6):1441-52
19019145
Bioconjug Chem. 1996 Sep-Oct;7(5):557-63
8889017
Mini Rev Med Chem. 2004 Jun;4(5):523-43
15180509
AIDS Res Hum Retroviruses. 2008 Nov;24(11):1357-63
19025416
Annu Rev Microbiol. 2008;62:271-88
18785839
Nature. 1992 May 21;357(6375):216-22
1589020
Proc Natl Acad Sci U S A. 1976 Nov;73(11):3825-32
1069267
J Virol. 2002 Dec;76(24):13001-14
12438626
Biophys Chem. 2002 Dec 10;101-102:145-53
12487996
J Biol Chem. 1991 Dec 5;266(34):23422-7
1744135
Bioconjug Chem. 1994 Jan-Feb;5(1):40-6
8199233
J Viral Hepat. 1999 May;6(3):165-81
10607229
Proc Natl Acad Sci U S A. 2006 May 9;103(19):7408-13
16651538
J Biol Chem. 1971 Mar 10;246(5):1496-503
5545092
Nat Rev Microbiol. 2007 Jun;5(6):453-63
17487147
Plant Cell. 1992 Feb;4(2):225-34
1633495
Cold Spring Harb Symp Quant Biol. 1995;60:461-78
8824420
Biochemistry. 1997 Sep 16;36(37):11051-4
9333321
Biochem J. 1998 Nov 1;335 ( Pt 3):481-90
9794784
Science. 2005 Jul 22;309(5734):623-6
15947137
Gastroenterology. 2007 May;132(5):1979-98
17484890
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2310-5
16461899
Bioconjug Chem. 1995 Sep-Oct;6(5):624-9
8974463
Nucleic Acids Res. 2010 Oct;38(19):6803-12
20558598
Antiviral Res. 2009 Jan;81(1):1-5
18948140
J Virol. 1997 Aug;71(8):6208-13
9223519
J Virol. 2009 Aug;83(15):7422-33
19458004
Protein Eng Des Sel. 2008 Oct;21(10):631-8
18723852
Nucleic Acids Res. 1991 Mar 25;19(6):1349
2030957
Nat Med. 2005 Jul;11(7):791-6
15951748
J Mol Biol. 2005 Apr 15;347(5):991-1003
15784258
J Cell Sci. 1999 Feb;112 ( Pt 4):467-75
9914159
Hepatology. 2009 Feb;49(2):364-77
19148942
Curr Pharm Des. 2006;12(11):1301-14
16611117
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9294-9
15939869
Clin Microbiol Rev. 1998 Oct;11(4):614-27
9767059
Int J Med Sci. 2006;3(2):29-34
16614739
J Virol. 2000 Mar;74(5):2293-304
10666260
Nature. 2005 Aug 18;436(7053):979-84
16107839
Aliment Pharmacol Ther. 2009 Apr 1;29(7):689-705
19183149